Cabaletta Bio (CABA) Change in Accured Expenses (2018 - 2025)

Cabaletta Bio's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at $3.1 million for Q4 2025.

• On a quarterly basis, Change in Accured Expenses rose 167.53% year-over-year to $3.1 million in Q4 2025; TTM through Dec 2025 was $7.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.4 million, changed N/A from the prior year.
• Change in Accured Expenses advanced to $3.1 million in Q4 2025 per CABA's latest filing, from $2.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $6.4 million in Q3 2024 and bottomed at -$4.5 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is $798500.0 (2023), against an average of $566850.0.
• Biggest YoY gain for Change in Accured Expenses was 878.15% in 2024; the steepest drop was 247.7% in 2024.
• Year by year, Change in Accured Expenses stood at $1.7 million in 2021, then tumbled by 77.18% to $395000.0 in 2022, then soared by 674.94% to $3.1 million in 2023, then tumbled by 247.7% to -$4.5 million in 2024, then soared by 167.53% to $3.1 million in 2025.
• Per Business Quant, the three latest CABA Change in Accured Expenses figures stand at $3.1 million (Q4 2025), $2.3 million (Q3 2025), and $5.6 million (Q2 2025).